US Stock MarketDetailed Quotes

PFE Pfizer

Watchlist
  • 25.010
  • -0.200-0.79%
Close Mar 27 16:00 ET
  • 25.070
  • +0.060+0.24%
Post 18:52 ET
141.74BMarket Cap17.74P/E (TTM)

About Pfizer Company

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Company Profile

SymbolPFE
Company NamePfizer
Listing DateJan 17, 1944
Founded1849
CEODr. Albert Bourla, D.V.M.,PhD
MarketNYSE
Employees81000
Fiscal Year Ends12-31
Address66 Hudson Boulevard East
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10001-2192
Phone1-212-733-2323

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Albert Bourla, D.V.M.,PhD
  • Chairman of the Board and Chief Executive Officer
  • 24.65M
  • Sally Susman
  • Chief Corporate Affairs Officer and Executive Vice President
  • --
  • Payal Sahni
  • Chief People Experience Officer and Executive Vice President
  • --
  • Lidia L. Fonseca
  • Executive Vice President, Chief Digital and Technology Officer
  • --
  • Michael McDermott
  • Executive Vice President, Chief Global Supply and Quality Officer
  • --
  • Douglas M. Lankler
  • Chief Legal Officer and Executive Vice President
  • --
  • David M. Denton
  • Chief Financial Officer and Executive Vice President
  • 8.12M
  • Alexandre de Germay
  • Chief International Commercial Officer and Executive Vice President
  • --
  • Aamir Malik
  • Chief U.S. Commercial Officer and Executive Vice President
  • 8.29M
  • Dr. Chris Boshoff, M.D.,PhD
  • Chief Scientific Officer and President, Research and Development
  • 7.85M
  • Dr. Andrew Baum, M.D.
  • Executive Vice President, Chief Strategy and Innovation Officer
  • --
  • Jennifer B. Damico
  • Principal Accounting Officer, Senior Vice President and Controller
  • --
  • Margaret M. Madden
  • Senior Vice President, Corporate Secretary and Chief Governance Counsel
  • --
  • Suzanne Nora Johnson
  • Independent Director
  • 410.00K
  • Shantanu Narayen
  • Lead Independent Director
  • 445.00K
  • Ronald E. Blaylock
  • Independent Director
  • 360.00K
  • Mortimer J. Buckley
  • Independent Director
  • 145.60K
  • Joseph J. Echevarria
  • Independent Director
  • 390.00K
  • James Robert Quincey
  • Independent Director
  • 380.00K
  • James C. Smith
  • Independent Director
  • 390.00K
  • Cyrus Taraporevala
  • Independent Director
  • 268.76K
  • Dr. Susan J. Hockfield, PhD
  • Independent Director
  • 363.00K
  • Dr. Susan D. Desmond-Hellmann, M.D.,M.P.H.
  • Independent Director
  • 360.00K
  • Dr. Scott Gottlieb,M.D.
  • Independent Director
  • 390.00K
  • Dr. Helen H. Hobbs, M.D.
  • Independent Director
  • 410.00K
  • Dr. Dan R. Littman, M.D.,PhD
  • Independent Director
  • 380.00K

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More